[ad_1] Recent experiments in cell cultures and in animals provide hope for the potential use of the CRISPR-Cas9 genetic engineering tool for the treatment of certain types of cancer. To understand, we interviewed Anna Gutkin, PhD student in nanomedicine, therapy through RNA, drug administration and co-author of the recent study …
Read More »